H2BFH (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K5-ac
___PDPAkSAPAPkk
Upstream
0 42
Treatment
  • vorinostat
H2BFH (human) ___PDPAkSAPAPkk K5-ac
K5-ub
___PDPAkSAPAPkk
0 39
H2BFH (human) ___PDPAkSAPAPkk K5-ub
K11-ac
AkSAPAPkkGSkkAV
Upstream
0 174
Treatment
  • vorinostat
H2BFH (human) AkSAPAPkkGSkkAV K11-ac
K12-ac
kSAPAPkkGSkkAVT
Upstream
0 181
Treatment
  • MS275
  • vorinostat
H2BFH (human) kSAPAPkkGSkkAVT K12-ac
K15-ac
PAPkkGSkkAVTkAQ
Upstream
0 184
Treatment
  • MS275
  • vorinostat
H2BFH (human) PAPkkGSkkAVTkAQ K15-ac
K16-ac
APkkGSkkAVTkAQk
Upstream
0 174
Treatment
  • MS275
  • vorinostat
H2BFH (human) APkkGSkkAVTkAQk K16-ac
K20-ac
GSkkAVTkAQkkDGK
0 171
H2BFH (human) GSkkAVTkAQkkDGK K20-ac
K20-ub
GSkkAVTkAQkkDGK
0 4
H2BFH (human) GSkkAVTkAQkkDGK K20-ub
K23-ac
kAVTkAQkkDGKKRK
0 133
H2BFH (human) kAVTkAQkkDGKKRK K23-ac
K24-ac
AVTkAQkkDGKKRKR
0 31
H2BFH (human) AVTkAQkkDGKKRKR K24-ac
S36-p
RKRSRKEsysIyVyK
0 44
H2BFH (human) RKRSRKEsysIyVyK S36-p
Y37-p
KRSRKEsysIyVyKV
0 6
H2BFH (human) KRSRKEsysIyVyKV Y37-p
S38-p
RSRKEsysIyVyKVL
0 3
H2BFH (human) RSRKEsysIyVyKVL S38-p
Y40-p
RKEsysIyVyKVLkQ
0 30
H2BFH (human) RKEsysIyVyKVLkQ Y40-p
Y42-p
EsysIyVyKVLkQVH
Upstream
0 38
Regulatory protein:
  • CSFR (human)
H2BFH (human) EsysIyVyKVLkQVH Y42-p
K46-ub
IyVyKVLkQVHPDTG
Upstream
0 113
Treatment
  • vorinostat
H2BFH (human) IyVyKVLkQVHPDTG K46-ub
K57-ac
PDTGISSkAMGIMNs
0 4
H2BFH (human) PDTGISSkAMGIMNs K57-ac
K57-ub
PDTGISSkAMGIMNs
0 24
H2BFH (human) PDTGISSkAMGIMNs K57-ub
S64-p
kAMGIMNsFVNDIFE
0 60
H2BFH (human) kAMGIMNsFVNDIFE S64-p
K85-ac
SRLAHYNkRsTItSR
Upstream
0 8
Treatment
  • MS275
  • vorinostat
H2BFH (human) SRLAHYNkRsTItSR K85-ac
K85-ub
SRLAHYNkRsTItSR
0 43
H2BFH (human) SRLAHYNkRsTItSR K85-ub
S87-p
LAHYNkRsTItSREI
0 4
H2BFH (human) LAHYNkRsTItSREI S87-p
T90-p
YNkRsTItSREIQTA
0 2
H2BFH (human) YNkRsTItSREIQTA T90-p
K108-ac
LLPGELAkHAVsEGT
Upstream
0 16
Treatment
  • MS275
H2BFH (human) LLPGELAkHAVsEGT K108-ac
K108-ub
LLPGELAkHAVsEGT
Upstream
0 111
Treatment
  • MG132
H2BFH (human) LLPGELAkHAVsEGT K108-ub
S112-p
ELAkHAVsEGTkAVT
0 7
H2BFH (human) ELAkHAVsEGTkAVT S112-p
K116-ac
HAVsEGTkAVTkYTS
0 12
H2BFH (human) HAVsEGTkAVTkYTS K116-ac
K116-ub
HAVsEGTkAVTkYTS
0 116
H2BFH (human) HAVsEGTkAVTkYTS K116-ub
K120-ac
EGTkAVTkYTSSk__
0 23
H2BFH (human) EGTkAVTkYTSSk__ K120-ac
K120-ub
EGTkAVTkYTSSk__
Upstream
0 116
Treatment
  • MG132
H2BFH (human) EGTkAVTkYTSSk__ K120-ub
K125-ac
VTkYTSSk_______
0 6
H2BFH (human) VTkYTSSk_______ K125-ac
K125-ub
VTkYTSSk_______
0 2
H2BFH (human) VTkYTSSk_______ K125-ub